Standout Papers

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease 2023 2026 2024135
  1. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease (2023)
    Jeffrey L. Cummings, Amanda M. Leisgang Osse et al. BioDrugs
  2. Genetic correlations between Alzheimer’s disease and gut microbiome genera (2023)
    Davis Cammann, Yimei Lu et al. Scientific Reports

Immediate Impact

5 standout
Sub-graph 1 of 2

Citing Papers

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
2024 Standout
Long COVID science, research and policy
2024 Standout
1 intermediate paper

Works of Davis Cammann being referenced

Genetic correlations between Alzheimer’s disease and gut microbiome genera
2023 Standout
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
2023 Standout

Author Peers

Author Last Decade Papers Cites
Davis Cammann 122 147 3 53 6 247
Amanda M. Leisgang Osse 79 142 2 29 8 239
Fredrik Eriksson 84 178 1 33 7 262
Ashley Selman 91 166 6 30 7 299
Bin‐Lu Sun 95 102 7 32 5 212
Amera A. Ebshiana 173 145 7 38 3 296
Paola Bisceglia 101 160 15 42 15 294
Mar Buendía 76 215 3 24 11 281
Miguel Marín 83 156 5 33 10 286
M. Mahafuzur Rahman 143 178 10 16 10 292
Teresa Pardo-Moreno 65 101 3 22 7 232

All Works

Loading papers...

Rankless by CCL
2026